Form 4: CVS CFO Brian Newman Executes Tax-Related Share Sale

CVS Health CFO Brian Newman disposed of 2,478 shares to satisfy tax withholding obligations following a restricted stock unit vesting.

Summary

• Brian Newman, EVP and Chief Financial Officer of CVS Health, reported the disposition of 2,478 shares of common stock.
• The transaction occurred on May 31, 2026, at a price of $90.98 per share.
• The disposition was executed to cover tax withholding obligations related to the vesting and settlement of restricted stock units.
• Following this transaction, the reporting person maintains a direct beneficial ownership of 3,008 shares of CVS common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax compliance rather than a market-driven divestment.

Positives

• The transaction was a routine administrative action related to tax obligations rather than a discretionary sale of equity.
• The reporting person retains a significant equity stake in the company following the transaction.

Negatives

• The transaction represents a reduction in the direct share ownership of a key executive.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that Form 4 filings regarding tax withholding upon the vesting of equity awards are standard industry practice for corporate executives and do not typically signal a change in management sentiment or strategic direction.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices observed across the S&P 500.
• The use of 'sell-to-cover' or share withholding for tax obligations is a common mechanism used by executives at companies like Walgreens Boots Alliance and UnitedHealth Group.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related settlement.

Key Dates

Keywords

CVS Health, CVS, Form 4, Insider Trading, Brian Newman, CFO, Executive Compensation